FindTrial
Sign In

Blood cell imaging for leukaemia detection

3 Dimensional Quantitative Phase Imaging study of Blood cells for the detection of Leukamia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/030933
Enrollment
72
Registered
2021-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C910- Acute lymphoblastic leukemia [ALL] Health Condition 2: C920- Acute myeloblastic leukemia Health Condition 3: C911- Chronic lymphocytic leukemia of B-cell type Health Condition 4: C921- Chronic myeloid leukemia, BCR/ABL-positive

Interventions

None listed

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cases-Patients with leukaemia before starting the treatment. Control-Healthy volunteers with no smoking and drinking habits.

Exclusion criteria

Exclusion criteria: Exclusion criteria cases- Individuals having diseases other than leukaemia are excluded. Exclusion criteria control-Individuals having any diseases or abnormalities are excluded.

Design outcomes

Secondary

MeasureTime frame
This technique may help to diagnose leukaemia at early stage.Timepoint: 3 years—

Primary

MeasureTime frame
A dedicated 3D Quantitative Phase Imaging system. Timepoint: 3 years—

Countries

India

Contacts

Public ContactDr Ajeetkumar Patil

Manipal Academy of HIgher Education

ajeetkumar.p@manipal.edu9986169590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026